Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioblastoma | D005909 | EFO_0000515 | — | 22 | 21 | 5 | — | — | 37 |
Gliosarcoma | D018316 | — | — | 16 | 15 | 4 | — | — | 26 |
Hiv infections | D015658 | EFO_0000764 | B20 | 4 | 6 | 3 | — | 1 | 13 |
Astrocytoma | D001254 | EFO_0000271 | — | 5 | 7 | 2 | — | — | 11 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 4 | 7 | 1 | — | — | 9 |
Non-small-cell lung carcinoma | D002289 | — | — | 4 | 5 | 2 | — | 1 | 9 |
Melanoma | D008545 | — | — | 3 | 4 | 1 | — | — | 6 |
Neoplasms | D009369 | — | C80 | 4 | 3 | 1 | — | — | 6 |
Oligodendroglioma | D009837 | EFO_0000631 | — | 2 | 3 | 1 | — | — | 5 |
Neuroblastoma | D009447 | EFO_0000621 | — | — | 3 | 1 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glioma | D005910 | EFO_0000520 | — | 6 | 9 | — | — | — | 12 |
Central nervous system neoplasms | D016543 | — | — | 3 | 3 | — | — | — | 5 |
Myelodysplastic syndromes | D009190 | — | D46 | 3 | 2 | — | — | — | 4 |
Myeloid leukemia acute | D015470 | — | C92.0 | 3 | 2 | — | — | — | 4 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 1 | — | — | — | 3 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 3 | 1 | — | — | — | 3 |
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 3 | 1 | — | — | — | 3 |
Myelomonocytic leukemia chronic | D015477 | — | C93.1 | 3 | 1 | — | — | — | 3 |
Hodgkin disease | D006689 | — | C81 | 2 | 1 | — | — | — | 3 |
Sarcoma | D012509 | — | — | 1 | 2 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 2 | — | — | — | — | 2 |
Hematologic neoplasms | D019337 | — | — | 1 | — | — | — | — | 1 |
Castration-resistant prostatic neoplasms | D064129 | — | — | 1 | — | — | — | — | 1 |
Primary myelofibrosis | D055728 | — | D47.4 | 1 | — | — | — | — | 1 |
Multiple myeloma | D009101 | — | C90.0 | 1 | — | — | — | — | 1 |
B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | — | — | — | — | 1 |
Bcr-abl positive chronic myelogenous leukemia | D015464 | EFO_0000340 | — | 1 | — | — | — | — | 1 |
Anemia | D000740 | HP_0001903 | D64.9 | 1 | — | — | — | — | 1 |
Leukemia myeloid chronic atypical bcr-abl negative | D054438 | — | C92.2 | 1 | — | — | — | — | 1 |
Myeloid leukemia chronic-phase | D015466 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Adenocarcinoma of lung | D000077192 | — | — | — | — | — | — | 1 | 1 |
Pelvic organ prolapse | D056887 | EFO_0004710 | — | — | — | — | — | 1 | 1 |
Drug common name | Vicriviroc |
INN | vicriviroc |
Description | (4,6-dimethyl-5-pyrimidinyl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]methanone is a member of (trifluoromethyl)benzenes. |
Classification | Small molecule |
Drug class | antivirals; antivirals, chemokine receptor (CCR) antagonists |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C |
PDB | — |
CAS-ID | 306296-47-9 |
RxCUI | — |
ChEMBL ID | CHEMBL82301 |
ChEBI ID | — |
PubChem CID | 3009355 |
DrugBank | — |
UNII ID | TL515DW4QS (ChemIDplus, GSRS) |